Logo image of DOX.MI

DOXEE SPA (DOX.MI) Stock Fundamental Analysis

BIT:DOX - IT0005394413 - Common Stock

2.41 EUR
+0.05 (+2.12%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

2

DOX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 101 industry peers in the Software industry. DOX may be in some trouble as it scores bad on both profitability and health. DOX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DOX had negative earnings in the past year.
DOX had a positive operating cash flow in the past year.
In multiple years DOX reported negative net income over the last 5 years.
Each year in the past 5 years DOX had a positive operating cash flow.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

The Return On Assets of DOX (-8.41%) is worse than 74.26% of its industry peers.
DOX has a worse Return On Equity (-43.22%) than 77.23% of its industry peers.
Industry RankSector Rank
ROA -8.41%
ROE -43.22%
ROIC N/A
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

DOX's Gross Margin of 71.32% is in line compared to the rest of the industry. DOX outperforms 52.48% of its industry peers.
In the last couple of years the Gross Margin of DOX has remained more or less at the same level.
DOX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

DOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOX has more shares outstanding than it did 1 year ago.
DOX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOX has been reduced compared to a year ago.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

DOX has an Altman-Z score of 0.49. This is a bad value and indicates that DOX is not financially healthy and even has some risk of bankruptcy.
DOX has a Altman-Z score of 0.49. This is amonst the worse of the industry: DOX underperforms 81.19% of its industry peers.
A Debt/Equity ratio of 1.37 is on the high side and indicates that DOX has dependencies on debt financing.
DOX has a worse Debt to Equity ratio (1.37) than 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.49
ROIC/WACCN/A
WACC7.99%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.62 indicates that DOX may have some problems paying its short term obligations.
DOX's Current ratio of 0.62 is on the low side compared to the rest of the industry. DOX is outperformed by 85.15% of its industry peers.
A Quick Ratio of 0.62 indicates that DOX may have some problems paying its short term obligations.
DOX's Quick ratio of 0.62 is on the low side compared to the rest of the industry. DOX is outperformed by 84.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.84%, which is quite impressive.
The Revenue has been growing slightly by 2.44% in the past year.
Measured over the past years, DOX shows a quite strong growth in Revenue. The Revenue has been growing by 11.31% on average per year.
EPS 1Y (TTM)45.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.05%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%1.74%

3.2 Future

The Earnings Per Share is expected to grow by 62.70% on average over the next years. This is a very strong growth
Based on estimates for the next years, DOX will show a quite strong growth in Revenue. The Revenue will grow by 10.40% on average per year.
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

DOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
DOX is valuated quite expensively with a Price/Forward Earnings ratio of 119.31.
Based on the Price/Forward Earnings ratio, DOX is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
DOX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.54.
Industry RankSector Rank
PE N/A
Fwd PE 119.31
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DOX is valued a bit cheaper than the industry average as 63.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.76
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

DOX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DOX's earnings are expected to grow with 62.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.7%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DOX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOXEE SPA

BIT:DOX (9/9/2025, 7:00:00 PM)

2.41

+0.05 (+2.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.96M
Analysts80
Price Target6.65 (175.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 119.31
P/S 1.06
P/FCF N/A
P/OCF 12.47
P/B 3.29
P/tB N/A
EV/EBITDA 15.76
EPS(TTM)-0.32
EYN/A
EPS(NY)0.02
Fwd EY0.84%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.19
OCFY8.02%
SpS2.28
BVpS0.73
TBVpS-1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.41%
ROE -43.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.32%
FCFM N/A
ROA(3y)-6.09%
ROA(5y)-1.79%
ROE(3y)-39%
ROE(5y)-17.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.72%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA 3.97
Cap/Depr 70.69%
Cap/Sales 13.87%
Interest Coverage N/A
Cash Conversion 76.19%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z 0.49
F-Score6
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)153.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.76%
Cap/Sales(5y)22.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.05%
EPS Next Y105.88%
EPS Next 2Y62.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.44%
Revenue growth 3Y8.28%
Revenue growth 5Y11.31%
Sales Q2Q%1.74%
Revenue Next Year10.63%
Revenue Next 2Y10.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4354.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.27%
OCF growth 3Y-10.06%
OCF growth 5Y-10.58%